Table 1.
Characteristics of patients
| Sedation | Nonsedation | P value | |
|---|---|---|---|
| Number of patients (N) | 171 | 218 | |
| Age (years) | 70.1 ± 13.9 | 74.8 ± 12.3 | < 0.01 |
| Gender, males | 123 (71.9%) | 133 (61.0%) | 0.03 |
| BMI (%) | 21.5 ± 3.9 | 21.2 ± 3.8 | 0.48 |
| ASA-PS classification I–II | 136 (79.5%) | 169 (77.5%) | 0.71 |
| Alcohol drinking | 76 (44.4%) | 80 (36.7%) | 0.14 |
| Smoking | 81 (47.4%) | 91 (41.7%) | 0.30 |
| Helicobacter pylori infection | 50 (29.2%) | 41 (18.8%) | 0.02 |
| Using antithrombotic agents | 45 (26.3%) | 86 (39.5%) | 0.01 |
| Using NSAIDs | 31 (18.1%) | 61 (28.0%) | 0.03 |
| Using gastric acid secretion inhibitor | 57 (33.3%) | 81 (37.2%) | 0.46 |
| Comorbidity | |||
| Cardiovascular diseases | 22 (12.9%) | 43 (19.7%) | 0.08 |
| Cerebrovascular diseases | 16 (9.4%) | 27 (12.4%) | 0.42 |
| Chronic kidney diseases | 28 (16.4%) | 46 (21.1%) | 0.25 |
| Chronic liver diseases | 46 (26.9%) | 38 (17.4%) | 0.03 |
| Diabetes mellitus | 49 (28.7%) | 56 (25.7%) | 0.57 |
| Hypertension | 90 (52.6%) | 123 (56.4%) | 0.47 |
| Malignant diseases | 51 (29.8%) | 56 (25.7%) | 0.42 |
| Charlson comorbidity score | 2.2 ± 1.8 | 2.0 ± 1.8 | 0.40 |
| Scoring system | |||
| Rockall score | 4.4 ± 1.4 | 4.7 ± 1.5 | 0.01 |
| Glasgow-Blatchford score | 9.8 ± 4.2 | 10.9 ± 3.8 | 0.01 |
| AIMS65 score | 1.4 ± 0.9 | 1.6 ± 1.0 | < 0.01 |
BMI body mass index, ASA-PS American Society of Anesthesiologists physical status, NSAIDs nonsteroidal anti-inflammatory drugs
Results are presented as mean ± SD or number of patients